MedXPress.Pro
ActiveMedXPress.Pro has been active since 2017 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €385k and a net result of €404k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 31% of 7740 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
Checked score
Score 2025
72
/ 100
Healthy
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency51▲+31
Growth78▲+20
Track record100
Bankruptcy probability, 12 months
0.3%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €25k at 30 days acceptable
Liquidity tight (current ratio 1.22 against 0.85 in 2024; short-term debt: 49.3% and cash: 0.4% of total assets), and 73.6% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 82
Relative position
BE, all sectors
reference
Sector 82
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
26.4%
Return on assets
27.7%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-07-2026, 1 day ahead of the deadline.
NBB · 9 filingsDeviation from the deadline
2025
1 d early
2024
7 d early
2023
6 d early
2022
5 d early
2021
6 d early
2020
2 d early
2019
3 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
21-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€385k
2024 · €-20k
2018: €34k
2019: €17k
2020: €-58k
2021: €-237k
2022: €-156k
2023: €-143k
2024: €-20k
2018 → 2025
Total assets
€1.46M▲ 243%
2024 · €424k
2018: €57k
2019: €185k
2020: €209k
2021: €147k
2022: €258k
2023: €294k
2024: €424k
2018 → 2025
Net result
€404k▲ 227%
2024 · €123k
2018: €37k
2019: €-17k
2020: €-75k
2021: €-179k
2022: €81k
2023: €13k
2024: €123k
2018 → 2025
Working capital
€157k
2024 · €-66k
2018: €9k
2019: €5k
2020: €-72k
2021: €-245k
2022: €-158k
2023: €-143k
2024: €-66k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€-237k-€-156k▲ 34.1%€-143k▲ 8.3%€-20k▲ 86.3%€385k
Operating result€-177k-€82k€15k▼ 82.2%€127k▲ 773%€527k▲ 316%
Net result€-179k-€81k€13k▼ 84.0%€123k▲ 855%€404k▲ 227%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 316% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.46M
Fixed assets
€582k▲ 1,144%
Current assets
€875k▲ 132%
Equity and liabilities €1.46M
Equity
€385k
Debt
€1.07M
Debt finances 73.6% of the balance-sheet total.
Key figures and ratios
EBITDA
€532k▲
2024 · €127k
Cash flow
€409k▲
2024 · €124k
Solvency
26.4%▲
2024 · -4.6%
Current ratio
1.22▲
2024 · 0.85
Quick ratio
1.22▲
2024 · 0.85
Debt / equity
2.79▲
2024 · -22.68
ROE
105.1%
ROA
27.7%▼
2024 · 29.1%
Interest coverage
230.14▲
2024 · 32.72
Debt
€1.07M▲
2024 · €444k
Debt ≤ 1 year
€718k▲
2024 · €444k
Debt > 1 year
€354k
Income taxes
€130k▲
2024 · €275
Staff costs
€249k▲
2024 · €225k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€424k€1.46M▲
Fixed assets21/28€47k€582k▲
Tangible fixed assets22/27€47k€42k▼
Furniture and vehicles24€4k€3k▼
Other tangible fixed assets26€43k€38k▼
Financial fixed assets28-€540k
Current assets29/58€378k€875k▲
Amounts receivable within one year40/41€289k€869k▲
Trade receivables40€190k€498k▲
Other amounts receivable41€100k€370k▲
Cash at bank and in hand54/58€88k€6k▼
Equity and liabilities
Total equity and liabilities10/49€424k€1.46M▲
Equity10/15€-20k€385k▲
Contributions10/11€6k€6k=
Reserves13€2k€378k▲
Distributable reserves133€2k€378k▲
Profit (loss) carried forward14€-28k€0▲
Amounts payable17/49€444k€1.07M▲
Amounts payable after more than one year17-€354k
Financial debts170/4-€354k
Amounts payable within one year42/48€444k€718k▲
Current portion of amounts payable after more than one year42-€51k
Trade debts44€187k€292k▲
Suppliers440/4€187k€292k▲
Taxes, remuneration and social security45€11k€22k▲
Taxes450/3€2k€0▼
Remuneration and social security454/9€9k€22k▲
Other amounts payable47/48€246k€353k▲
Income statement
Code20242025
Remuneration, social security and pensions62€225k€249k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€151€5k▲
Other operating charges640/8€13k€6k▼
Gross operating margin9900€365k€787k▲
Operating profit (loss)9901€127k€527k▲
Financial income75/76B€791€10k▲
Recurring financial income75€791€10k▲
Financial charges65/66B€4k€2k▼
Recurring financial charges65€4k€2k▼
Profit (loss) for the period before taxes9903€124k€534k▲
Income taxes67/77€275€130k▲
Profit (loss) for the period9904€123k€404k▲
Profit (loss) for the period to be appropriated9905€123k€404k▲
Appropriation of the result
Profit (loss) to be appropriated9906€-28k€376k▲
Profit (loss) brought forward from the previous period14P€-151k€-28k▲
Transfer to equity691/2-€376k
To other reserves6921-€376k
The notes to these accounts (12 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
30-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Highest result since 2018net €404k ▲227%
Operating result €527k, net result €404k, both a record.
31-12
Financial
Equity above €200kEq €385k
4 profitable years in a row build equity to €385k.
24-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
25-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
26-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial
Back to profitnet €81k
Net result €81k after 3 loss-making years.
25-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial
Weakest financial yearnet €-179k
Net result drops to €-179k, the lowest in the series; recovery starts the following year.
29-07
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
28-07
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
10-07
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
19-07
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Leuven · 1 establishment unit since 2017
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Slachthuislaan 13000 LeuvenGround area
1,927 m²
Building footprint
883 m²
Volume, LiDAR
10,686 m³
Parcel 24504E0450/00M000, Flanders · tallest building 15.0 m, ±4 floors. Linked by address, not a title deed.
1 establishment unit
MedXPress.Pro
since 20172.341.925.438
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24504E0450/00M000 | Flanders | 1,927 m² | 1 · 883 m² | 14.9 m · 4 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
SWENTIBOLD
BE 0452.189.848
Menen · Eq €385k
sciBASICS
BE 0893.600.424
Rochefort · Eq €384k
COVANCO
BE 0461.350.608
Izegem · Eq €384k
OTRA COSA
BE 0646.940.906
Mouscron · Eq €383k
SERVICE FACTURATION INFIRMIER SOINS DOMICILE DOUR
BE 0837.410.896
Dour · Eq €383k
Of 11,225 companies in sector 82100 we hold annual accounts for 3,511. 2,136 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded30-03-2017
Fiscal year end31-12
Activities, NACEBEL
46460Wholesale of pharmaceutical and medical goods
82100Office administrative and support services
82110Office administrative, office support and other business support activities
Sources
Crossroads Bank for EnterprisesNational Bank · 9 filingsAddress and cadastre registers
Data from official sources, last processed on 19-09-2026. Scores and ratios are computed by Checked and are not a credit decision.